A Recent Study Says That “Nuclear Medicine Market” Will Make a Huge Impact by 2024
Axiom MRC Added a, “Nuclear Medicine Market Report, By
Type, Procedure, Application and Geography – Global Market Share, Trend
Analysis & Forecast Up To 2024” Nuclear
medicine imaging procedures are non-invasive and, except for intravenous
injections, are generally painless medical tests that help doctors to diagnose
and assess medical conditions.
Nuclear
Medicine Market Outlook:
Nuclear medicine
or Radiopharmaceuticals is a division of medical imaging, which uses small
quantities of radioactive material to analyses and determine severity of
diseases, including cancers types, heart disease, gastrointestinal, endocrine,
neurological disorders and other abnormalities within the body.
The global
nuclear medicine market has gained sustainable growth owing to increasing
number of new cancer and cardiovascular cases, since nuclear medicines are used
as a diagnostic tool for these diseases. Continuing research and studies
demonstrating positive results is widening the scope of radioisotope
applications for the diagnosis and treatment of bone diseases, respiratory
diseases, thyroid-related diseases, and conditions of the digestive tract.
Along with these applications, the radioisotopes are principally used in radio
pharmacology to study drug movement in laboratory subjects.
Nuclear
Medicine Market Segmentation:
Nuclear Medicine Market by Type:
Based on type,
the global nuclear medicines market is segmented into diagnostic nuclear
medicine and therapeutic nuclear medicine.
Nuclear Medicine Market by Application:
Based on
application, the nuclear medicine market is divided into diagnostic
applications and therapeutic applications. Some major conditions covered in the
therapeutic applications are thyroid, bone metastasis, lymphoma, endocrine
tumors and others.
Nuclear Medicine Market by Procedure:
Based on
procedure, this market is segmented into diagnostic procedures (SPECT
radiopharmaceuticals and PET Radiopharmaceuticals) and therapeutic procedures
(beta emitters, alpha emitters and brachytherapy).
Nuclear Medicine Market by Geography:
Nuclear medicines
market is studied across the countries of key regions such as, North America,
Europe, Asia Pacific and rest of the world regions which includes Latin
America, and Middle East & Africa. North America comprises United States,
Canada and Mexico whereas Europe would primarily cover Germany, France, UK, Italy
and Rest of Europe.
Nuclear
Medicine Market Key Players:
Some of the
market players in the nuclear medicines include Bayer AG, Cardinal Health,
Mallinckrodt PLC, GE Healthcare, Lantheus Medical Imaging, Inc., Bracco Imaging
S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Siemens Healthcare,
Advanced Accelerator Applications S.A., Jubilant Pharma and among others.
About
Us:
Axiom Market Research & Consulting™ (also known as
Axiom MRC), is a full-service market research and data analytics firm, driven
by a simple aim of providing key market intelligence to companies to assist
them in taking informed business decisions pertaining to their marketing
strategy, investments, new product launches, market competition, consumer or
end users, social media trends etc.
Contact
Us:
Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: sales@axiommrc.com
Tel: +1(845)875-9786, +44(0) 20 238697007
Comments
Post a Comment